Alisa Opar is a California-based science writer and the articles editor at Audubon magazine.
Alisa Opar
Freelance writer
Simons Foundation
From this contributor
In search of truce in the autism wars
The fight between those who define autism as a medical condition and those who see it as a mere difference has reached vitriolic levels. Can the two sides come together to support all autistic people?
New group faces backlash over its goals for severe autism
A new advocacy group for people with severe autism taps into the deep divide in the community over who should speak for those on the spectrum.
New group faces backlash over its goals for severe autism
By
Alisa Opar
4 February 2019 | 6 min read
How to help low-income children with autism
Autistic children from low-income families are undercounted and underserved, a gap community leaders are working to bridge.
The healthcare system is failing autistic adults
Adults on the spectrum frequently have a range of other conditions — but they rarely get the help they need.
Why children with ‘severe autism’ are overlooked by science
Children with ‘severe autism’ are the most in need of help, yet the most overlooked in research. A new initiative is making them the primary focus.
Why children with ‘severe autism’ are overlooked by science
By
Alisa Opar
18 October 2017 | 21 min read
Explore more from The Transmitter
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
By
The Transmitter
21 November 2025 | 6 min read
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
By
Charles Q. Choi
20 November 2025 | 5 min read
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
By
Paul Middlebrooks
19 November 2025 | 1 min read